Delivery Order SPE2DX22D0010-SPE2D826FAV98
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $6.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate hydrochloride, a controlled pharmaceutical commonly prescribed for attention deficit hyperactivity disorder. This firm fixed-price delivery order, issued on October 7, 2025, carries a ceiling value of $1,036.04 and represents a non-competitive set-aside contract. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Methylphenidate ER 18 mg tablets (100-count units) under a firm fixed-price contract valued at $1,831.30. The award, made on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Methylphenidate ER (extended-release) tablets at 54mg dosage. This firm fixed-price delivery order, valued at $6,673.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for methylphenidate ER 36 mg tablets (100 count) on November 7, 2025, with a ceiling value of $2,593.37 and completion deadline of November 10, 2025. This competitively awarded contract utilizing firm fixed pricing represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Methylphenidate Extended Release 36mg tablets (100 count) with a ceiling value of $3,248.16 under a firm fixed-price contract type. The award was issued on August 11, 2025, with an ultimate completion date of the same day, and represents a non-set-aside, competitively awarded procurement from the Defense Logistics Agency's Medical Supply Chain. This...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,020.56 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Methylphenidate ER Tablets 18mg. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger $999.999 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Methylphenidate ER(LA) 20mg tablets (100-count units) under a firm fixed-price contract valued at $1,511.72. This is a non-set-aside competitive award with an ultimate completion date of July 29, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The place of performance is the vendor's corporate office in...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 100s, a controlled pharmaceutical medication commonly used in attention deficit treatment. This competitively awarded, non-set-aside delivery order carries a ceiling value of $6,053.14 with firm fixed pricing and was awarded on May 27, 2025, with a completion date of May 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.40 to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Methylphenidate is a central nervous system stimulant commonly used in military and veteran...